ORKA vs. EQ
ORKA (Oruka Therapeutics, Inc) and EQ (Equillium Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ORKA returned 36.46%/yr vs -16.50%/yr for EQ. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
ORKA vs. EQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ORKA achieves a 218.41% return, which is significantly higher than EQ's 41.94% return.
ORKA
- 1D
- -1.38%
- 1M
- 13.26%
- 6M
- 181.95%
- YTD
- 218.41%
- 1Y
- 609.63%
- 3Y*
- 93.94%
- 5Y*
- 36.46%
- 10Y*
- -12.31%
- ALL TIME*
- -28.21%
EQ
- 1D
- -5.17%
- 1M
- -24.40%
- 6M
- 54.93%
- YTD
- 41.94%
- 1Y
- 209.86%
- 3Y*
- 43.73%
- 5Y*
- -16.50%
- 10Y*
- —
- ALL TIME*
- -21.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.16M | $2.28M | $2.35M | |
| $77.59M | $103.90M | $107.56M |
ORKA vs. EQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ORKA Oruka Therapeutics, Inc | 218.41% | 56.32% | 76.73% | -28.27% | 10.23% | -46.38% | -29.77% | -4.88% | -40.45% |
EQ Equillium Inc | 41.94% | 107.16% | 3.49% | -31.79% | -71.88% | -29.53% | 58.28% | -58.58% | -43.14% |
Correlation
The correlation between ORKA and EQ is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 12, 2018 | 0.17 |
Fundamentals
ORKA:
$3.61B
EQ:
$78.15M
ORKA:
-$2.27
EQ:
-$0.26
ORKA:
11.01
EQ:
3.56
ORKA:
$0.00
EQ:
$0.00
ORKA:
-$71.00K
EQ:
-$83.00K
ORKA:
-$125.61M
EQ:
-$19.95M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ORKA vs. EQ — Risk / Return Rank
ORKA
EQ
ORKA vs. EQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oruka Therapeutics, Inc (ORKA) and Equillium Inc (EQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ORKA | EQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +5.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.65 | ||
| Omega ratioGain probability vs. loss probability | 1.68 | 1.47 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 22.00 | 8.07 | +13.93 |
| Martin ratioReturn relative to average drawdown | 71.65 | 17.56 | +54.09 |
Loading charts...
Drawdowns
ORKA vs. EQ - Drawdown Comparison
The maximum ORKA drawdown since its inception was -100.00%, roughly equal to the maximum EQ drawdown of -98.91%. Use the drawdown chart below to compare losses from any high point for ORKA and EQ.
Loading charts...
Drawdown Indicators
| ORKA | EQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -98.91% | -1.09% |
Max Drawdown (1Y)Largest decline over 1 year | -27.99% | -57.79% | +29.80% |
Max Drawdown (3Y)Largest decline over 3 years | -77.76% | -90.33% | +12.57% |
Max Drawdown (5Y)Largest decline over 5 years | -77.76% | -95.85% | +18.09% |
Max Drawdown (10Y)Largest decline over 10 years | -98.10% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -91.70% | -8.30% |
Average DrawdownAverage peak-to-trough decline | -93.90% | -85.03% | -8.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.58% | 26.51% | -17.93% |
Volatility
ORKA vs. EQ - Volatility Comparison
Oruka Therapeutics, Inc (ORKA) and Equillium Inc (EQ) have volatilities of 20.74% and 21.32%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ORKA | EQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.74% | 21.32% | -0.58% |
Volatility (6M)Calculated over the trailing 6-month period | 53.50% | 66.39% | -12.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.13% | 163.27% | -85.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 72.55% | 115.10% | -42.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 152.67% | 286.04% | -133.37% |
Dividends
ORKA vs. EQ - Dividend Comparison
Neither ORKA nor EQ has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
EQ Equillium Inc | 0.00% | 0.00% | 0.00% |
ORKA Oruka Therapeutics, Inc | 0.00% | 0.00% | 99.82% |
Financials
ORKA vs. EQ - Financials Comparison
This section allows you to compare key financial metrics between Oruka Therapeutics, Inc and Equillium Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ORKA and EQ have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EQ has higher volatility (21.32%) compared to ORKA (20.74%). In terms of maximum drawdown, ORKA dropped -100.00% vs EQ's -98.91%.
ORKA currently has the higher Sharpe Ratio (7.88 vs 2.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ORKA and EQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer